Leonteq Securities AG’s Health Catalyst HCAT Stock Holding History

Leonteq Securities AG’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46	Hold	23	–	–	﹤0.01%	1258
2026 Q1	$29	Hold	23	–	–	﹤0.01%	1270
2025 Q4	$55	Hold	23	–	–	﹤0.01%	1415
2025 Q3	$66	Hold	23	–	–	﹤0.01%	1307
2025 Q2	$87	Hold	23	–	–	﹤0.01%	1248
2025 Q1	$104	Hold	23	–	–	﹤0.01%	1208
2024 Q4	$160	Buy	+23	New	+$183	﹤0.01%	1227
2024 Q3	–	Sell	-624	Closed	-$3.99K	–	1234
2024 Q2	$3.99K	Hold	624	–	–	﹤0.01%	1065
2024 Q1	$4.7K	Hold	624	–	–	﹤0.01%	1090
2023 Q4	$5.78K	Buy	624 +287	+85%	+$2.35K	﹤0.01%	1043
2023 Q3	$3.41K	Hold	337	–	–	﹤0.01%	1102
2023 Q2	$4.21K	Sell	337 -509	-60%	-$6.06K	﹤0.01%	1124
2023 Q1	$9.87K	Buy	846 +623	+279%	+$7.94K	﹤0.01%	1028
2022 Q4	$2.37K	Hold	223	–	–	﹤0.01%	1187
2022 Q3	$2.16K	Buy	223 +30	+16%	+$397	﹤0.01%	1184
2022 Q2	$2.8K	Buy	+193	New	+$3.29K	﹤0.01%	1183

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CDC Financial Chicago, Illinois $239M AUM

PVM

Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Leonteq Securities AG's HCAT Position: Q2 2026 in Review

Leonteq Securities AG held its Health Catalyst (HCAT) position steady in Q2 2026 at 23 shares worth $46. The position accounts for ﹤0.01% of the portfolio, ranked #1258.

Leonteq Securities AG first reported a position in HCAT in Q2 2022 and has held it in 16 quarters since. The position peaked at $9.87K in Q1 2023. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

Leonteq Securities AG held 23 shares of Health Catalyst worth $46 as of Q2 2026.
Leonteq Securities AG left its Health Catalyst share count unchanged in Q2 2026.
Health Catalyst made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1258 holding.
Leonteq Securities AG first reported a position in Health Catalyst in Q2 2022 and has held it in 16 quarters since.
Leonteq Securities AG's Health Catalyst position peaked at $9.87K in Q1 2023.
127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.